期刊文献+

凉血化瘀方对MRL/lpr小鼠自身抗体及血清白细胞介素-6、17、21表达的影响 被引量:3

Effects of Blood-cooling and Blood-stasis-removing Decoction on Autoantibody and Serum Levels of Interleukins 6, 17, 21 in MRL/lpr Experimental Rats
下载PDF
导出
摘要 【目的】观察中药复方凉血化瘀方对自发性系统性红斑狼疮(SLE)模型MRL/lpr小鼠抗双链DNA抗体(ds DNA)、抗核小体抗体(Anu A)及血清白细胞介素6(IL-6)、IL-17、IL-21表达的影响。【方法】实验小鼠分为空白对照组、模型组、中药高剂量组(剂量为25.2 g/kg)、中药低剂量组(剂量为12.6 g/kg),连续给药8周,眼眶取血并分离血清,采用酶联免疫吸附(ELISA)法检测抗ds DNA抗体、Anu A、IL-6、IL-17、IL-21水平。【结果】模型组小鼠血清自身抗体和IL-6、IL-17、IL-21水平较空白对照组显著升高(P<0.01),中药组血清抗体和细胞因子水平较模型组降低,其中中药高剂量组与模型组比较,差异均有统计学意义(P<0.01)。【结论】凉血化瘀方能降低自身抗体水平,抑制炎性细胞因子的表达,是其有效治疗SLE的机制之一。 Objective To observe the effect of blood-cooling and blood-stasis-removing Decoction on anti-double-strain DNA( anti-ds DNA) antibody, anti-nucleosome antibody( Anu A) and serum levels of interleukin( IL)-6, 17, 21 in spontaneous systemic lupus erythematosus( SLE) MRL/lpr experimental rats.Methods The experimental rats were divided into blank control group, model group, and high-and low-dose Chinese medicine groups( 25.2, 12.6 g/kg respectively), the treatment lasting 8 weeks. At the end of the experiment, the blood taken from the orbital veins was separated for obtaining serum, and then the serum anti-ds DNA antibody, Anu A, IL-6,17,21 levels were tested by enzyme-linked immunosorbent assay( ELISA).Results The serum autoantibody and IL-6, 17, 21 levels of rats in the model group were increased significantly as compared with the blank control group( P〈0.01). The serum antibody and cytokine levels of Chinese medicine groups were reduced as compared with the model group, the difference between high-dose Chinese medicine group and model group being significant( P〈0.01). Conclusion Blood-cooling and blood-stasis-removing Decoction has certain effect on reducing the serum levels of anti-ds DNA antibody, Anu A, and IL-6,17,21, which may coniribute to one of its therapeutic mechanisms for SLE.
出处 《广州中医药大学学报》 CAS 2015年第6期1055-1058,共4页 Journal of Guangzhou University of Traditional Chinese Medicine
基金 国家中医药管理局课题(编号:YUBJ2011KF-6) 江苏省2012年度普通高校研究生创新课题(编号:CXZZ12-0606)
关键词 凉血化瘀方/药理学 系统性红斑狼疮/中药疗法 自身抗体 细胞因子 疾病模型 动物 小鼠 Blood-cooling and blood-stasis-removing Decoction/pharmacology Systematic lupus erythematosus/ TCD therapy Autoantibody Cytokines Disease models animal Mice
  • 相关文献

参考文献12

  • 1朱震,张世勤,汪悦.中西医结合治疗系统性红斑狼疮32例临床研究[J].江苏中医药,2012,44(11):25-26. 被引量:6
  • 2贺石林.中医科研设计与统计学[M].长沙:湖南科学技术出社,2007:110.
  • 3Santiago-Raber M L, Laporte C, Reininger L, et al. Genetics basis of murine lupus[J]. Autoimmun Rev, 2004, 3 (1) : 33.
  • 4陈志强.自身免疫小鼠中狼疮皮病的发病机理-在MRL/Mp-+,+小鼠中诱导表皮下免疫球蛋白沉积的尝试[J].国外医学:皮肤性病学分册,1994,20(5):309.
  • 5Charles P J. Defective waste disposal: does it induce autoantibodies in SLE [J]. Ann Rheum Dis, 2003, 62 (1): 1.
  • 6Gonzalez C, Garcia-Berroeal B, Herraez O, et al. Anti- nucleosome, anti -chronmatin, anti -dsDNA and anti -histone antibody reactivity in systemic lupus erythematosus[J]. Clin Chem Lab Med, 2004, 42 (3): 266.
  • 7Simon J A, Cabiedes J, Ortiz E, et al. Anti-nueleosome antibodies in patients with systemic lupus erythematosus of recent onset. Potential utility as a diagnostic tool and disease activity marker[J]. Rheumatology, 2004, 43 (2): 220.
  • 8金卫东,俞晓洁,贾敬年,周永列.系统性红斑狼疮患者血清抗核小体抗体与抗C1q抗体的检测及临床意义[J].中国中西医结合肾病杂志,2007,8(10):601-604. 被引量:3
  • 9Chun H Y, Chung J W, Kim H A, et al. Cytokine IL-6 and IL-10 as biomarkers in systemic lupus erythematosus[J]. J Clin Immunol, 2007, 27 (5): 461.
  • 10Nalbandian A, Crispin J C, Tsokos G C. lnterleukin-17 and systemic lupus erythematosus: current concepts[J1. Clin Exp Immunol, 2009, 157 (2): 209.

二级参考文献12

  • 1Tan EM,Cohen AS,Fries JF,et al.The 1982 revised criteria for the classification of systemic lupus erythematosus.Arthritis Rheum,1982,25(1):1271-1277.
  • 2Bombardier C,Gladman DD,Urowitz MB,et al.Derivation of the SLEDAI:a disease activity index for lupus patients.The Committee on Prognosis studies in SLE.Arthritis Rheum,1992,35(6):630-640.
  • 3Agnello V,Koffler D,Eisenberg JW,et al.C1q precipitins in the sera of patients with systemic lupus erythematosus and other hypocomplementemic states:characterization of high and low molecular weight types.J Exp Med,1971,134(3 Pt 2):228s-241s.
  • 4Uwatoko S,Mannik M.Low-molecular weight C1q-binding immunoglobulin G in patients with systemic lupus erythematosus consists of autoantibodies to the collagen-like region of C1q.J Clin Invest,1998,82(3):816-824.
  • 5Monova D,Monov S,Rosenova K,et al.Autoantibodies against C1q:view on association between systemic lupus erythematosus disease manifestation and C1q autoantibodies.Ann Rheum Dis,2002,61(6):563-564.
  • 6Trendeleburg M,Marfurt J,Gerber I,et al.Lack of occurrence of severe lupus nephritis among anti-C1q autoantibody-negative patients.Arthritis Rheum,1999,42(1):187-188.
  • 7Emiem W,Niebur J,Kadera R.Accelerated in vitro apoptosis of lymphocytes from patients with systemic lupus erythematosus.J Immunol,1994,152(7):3685-3692.
  • 8Rekvig OP,Moens U,Sundsfjord A,et al.Experimental expression in mice and spontaneous expression in human SLE of polyomavirus T-antigen.A molecular basis for induction of antibodies to DNA and eukaryotic transcription factors.J Clin Invest,1997,99(8):2045-2054.
  • 9Charles PJ.Defective waste disposal:does it induce autoantibodies in SLE? Ann Rheum Dis,2003,62(1):1-3.
  • 10Alba P,Bento L,Cuadrado MJ,et al.Anti-dsDNA,anti-Sm antibodies,and the lupus anticoagulant:significant factors associated with lupus nephritis.Ann Rheum Dis,2003,62(6):556-560.

共引文献38

同被引文献66

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部